Skip to main content

David Berman

Equibles does not estimate personal net worth.

About David Berman

Immunocore Holdings plc reported in an 8-K filed January 30, 2026 that David Berman resigned as Head of Research & Development, effective February 27, 2026. The same filing states: “Dr. Berman’s decision to resign was not the result of any disagreement between Dr. Berman and the Company or any matter relating to the Company’s operations, policies, or practices.” The proxy statement of Immunocore Holdings plc reports total compensation of $4,278,988 for David Berman in fiscal 2025, including a base salary of $540,000. Disclosed compensation is on record for 3 fiscal years.

“On January 27, 2026, David Berman notified Immunocore Holdings plc (the "Company") of his decision to resign as Head of Research & Development of the Company, effective as of February 27, 2026, in order to pursue another opportunity.”
“Dr. Berman’s decision to resign was not the result of any disagreement between Dr. Berman and the Company or any matter relating to the Company’s operations, policies, or practices.”
Immunocore Holdings plc Form 8-K, filed January 30, 2026 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Immunocore Holdings plc (IMCR) $540,000 $4,278,988
2024 Immunocore Holdings plc (IMCR) $535,833 $5,481,495
2023 Immunocore Holdings plc (IMCR) $515,000 $4,396,622

Recent activity